Thus, IM activates the FGF-2/FGFR autocrine loop in various IM-resistant GIST cell lines and this mechanism might have a negative impact on the disease progression due to the activation of tumor cell migration, invasion, and enrichment of tumors with stem-like cell (SC) properties. The gene discussed is FGF2; the disease is gastrointestinal stromal tumor.